Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fmoc Solid Phase Peptide Synthesis (SPPS). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110041407B details a novel Fmoc-based fragment condensation for Deserelin acetate, offering superior purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.